Pulling SEC filings + quote and writing the call…
Pulling SEC filings + quote and writing the call…

Kodiak Sciences Inc.
Next earnings Aug 11, 2026 · consensus $-0.97 EPS
Last earnings -4.8% on 2026-05-07
Mixed signals in the latest filings.
Kodiak Sciences Inc. shows limited reported revenue, and -146.1% ROE.
Sources: SEC EDGAR (CIK 0001468748, latest 10-Q filed 2026-05-07) · EODHD · as of 6/22/2026, 1:52:48 PM.
Research and education only — not financial advice. Calls are generated from SEC filings and a delayed/third-party price feed, may be wrong or out of date, and are not a recommendation to buy or sell any security. Do your own research.
The risks, catalysts, 12-month price target and the cited SEC figures behind this rating — with Pro.
Unlock with Pro€15/mo · cancel anytime
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | — |
| Gross profit | — | — | — | — | — |
| Operating income | -$267M | -$341M | -$277M | -$187M | -$234M |
| Net income | -$267M | -$334M | -$260M | -$176M | -$230M |
| Diluted EPS | -$5.16 | -$6.39 | -$4.97 | -$3.35 | -$4.32 |
| Net margin | — | — | — | — | — |
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
1483 tracked peers · median
Disclosed under the STOCK Act
Self-reported periodic transaction reports (STOCK Act). Amounts are disclosed ranges; a trade may be a spouse's. Disclosures lag the trade by up to ~45 days. Source: House Clerk + Senate eFD.
Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.
Recent news tone vs the market's typical (which skews positive). A soft signal, not a recommendation.
Last 90 days: 0 open-market buys · 6 sales
| 2026-06-04 | BORGESON JOHN A. Chief Financial Officer | Exercise | 30.0K @ $1.04 | $31.2K |
| 2026-06-04 | BORGESON JOHN A. Chief Financial Officer | Sell | 25.9K @ $34.01 | $881K |
| 2026-06-04 | BORGESON JOHN A. Chief Financial Officer | Sell | 4.10K @ $34.67 | $142K |
| 2026-04-15 | BORGESON JOHN A. Chief Financial Officer | Exercise | 28.6K @ $1.04 | $29.8K |
| 2026-04-02 | BORGESON JOHN A. Chief Financial Officer | Exercise | 30.0K @ $1.04 | $31.2K |
| 2026-04-02 | BORGESON JOHN A. Chief Financial Officer | Sell | 12.7K @ $39.14 | $497K |
| 2026-04-02 | BORGESON JOHN A. Chief Financial Officer | Sell | 12.5K @ $40.29 | $503K |
| 2026-04-02 | BORGESON JOHN A. Chief Financial Officer | Sell | 4.23K @ $40.88 | $173K |
| 2026-04-02 | BORGESON JOHN A. Chief Financial Officer | Sell | 600.00 @ $41.77 | $25.1K |
| 2026-03-25 | PERLROTH VICTOR Chairman and CEO | Exercise | 300K @ $1.04 | $312K |
| 2025-12-18 | BAKER BROS. ADVISORS LP Director | Buy | 217K @ $23.00 | $5.00M |
| 2025-12-18 | BAKER BROS. ADVISORS LP Director | Buy | 2.39M @ $23.00 | $55.0M |